Document Security Systems Inc.’s (NYSEAMERICAN: DSS) wholly-owned subsidiary Impact Biomedical Inc. has released several updates of its main research projects, including breakthroughs in treatment protocols, significant collaborations, and global licensing prospects. The announcement of the updates is a start for the next phase of Impact Biomedical’s research agenda and positioning […]